Legend:
CC = Colorado Convention Center H = Hyatt Regency Denver at Colorado Convention Center
* = applied session ! = JSM meeting theme
Activity Details
|
|
447 * !
|
Wed, 7/31/2019,
8:30 AM -
10:20 AM
|
CC-201
|
Recent Advances in Propensity Score Methods for Observational Studies with Multiple Treatments — Invited Papers
|
Health Policy Statistics Section, Biopharmaceutical Section, Section on Statistics in Epidemiology
|
Organizer(s): Elande Baro, US Food and Drug Administration; Jessica Kim, US Food and Drug Administration
|
Chair(s): Jessica Kim, US Food and Drug Administration
|
8:35 AM
|
Generalized Propensity Score Matching: Updates and Challenges Toward Establishing Best Practices
Douglas Faries, Eli Lilly & Company; Zhanglin Cui, Eli Lilly & Company; Li Li, Eli Lilly & Company; Shu Yang, North Carolina State University; Shuhan Tang, The Ohio State University
|
9:00 AM
|
Approximate Bayesian Bootstrap Procedures to Estimate Multilevel Treatment in Observational Studies with Application to Type 2 Diabetes Treatment Regimens
Roee Gutman, Brown University; Anthony D. Scotina, Simmons University; Robert J Smith, Brown University; Andrew R Zullo, Brown University
|
9:25 AM
|
Utility of Regression Splines for Propensity Score Adjustment in Post Market Safety Analyzes with Multiple Treatments
Elande Baro, US Food and Drug Administration; Yuxi Tian, University of California Los Angeles; Rongmei Zhang, Food and Drug Administration; Yuqin Wei, Acumen LLC; Mao Hu, Acumen LLC; Jiemin Liao, Acumen LLC; Sandia Akhtar, Acumen LLC; Michael Wernecke, Acumen LLC; Jeffrey Kelman, Centers for Medicare & Medicaid Services; David Graham, Acumen LLC
|
9:50 AM
|
Discussant: Jessica M Franklin, Brigham and Women’s Hospital and Harvard Medical School
|
10:00 AM
|
Discussant: Yi Huang, University of Maryland Baltimore Country
|
10:10 AM
|
Floor Discussion
|
|